{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:40:47Z","timestamp":1794256847682,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To investigate chemotherapy dosage-related cognitive impairment and its neural mechanisms in breast cancer (BC) patients. Twenty-eight breast cancer patients after each chemotherapy cycle and matched 29 healthy control subjects underwent structural magnetic resonance imaging. Voxel-based morphometry analysis was performed to compare group differences in the gray matter for the whole brain. Furthermore, mediation analysis was conducted to explore the role of brain structures in chemotherapy dosage-related cognitive impairment. Voxel-based morphometry analysis was performed in gray matter for the whole brain of BC patients after chemotherapy. The results revealed that the gray matter density in the left inferior frontal gyrus, right middle frontal gyrus, right fusiform area, and bilateral cerebellum was decreased in the BC patients compared to controls. The number of chemotherapy cycles was negatively associated with general cognitive capacity, verbal fluency and digit span performance in the BC patients. In addition, decreased gray matter density in the right middle frontal gyrus could mediate the chemotherapy dosage effects on verbal fluency performance. These findings indicate that the dose-response relationship between chemotherapy and cognitive impairment may depend on the decreases in gray matter density of the frontal cortical structures.<\/jats:p>","DOI":"10.1038\/s41598-018-32257-w","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:12:54Z","timestamp":1536570774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients"],"prefix":"10.1038","volume":"8","author":[{"given":"Xiu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herta H.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiang-Shan R.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaidong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"32257_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1017\/S1355617714000149","volume":"20","author":"K Edelstein","year":"2014","unstructured":"Edelstein, K. & Bernstein, L. J. Cognitive dysfunction after chemotherapy for breast cancer. Journal of the International Neuropsychological Society: JINS 20, 351\u2013356 (2014).","journal-title":"Journal of the International Neuropsychological Society: JINS"},{"key":"32257_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/pon.3539","volume":"23","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment. Psycho-oncology 23, 1165\u20131171 (2014).","journal-title":"Psycho-oncology"},{"key":"32257_CR3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/pon.3291","volume":"22","author":"HD Cheng","year":"2013","unstructured":"Cheng, H. D. et al. Chemotherapy-induced prospective memory impairment in patients with breast cancer. Psycho-oncology 22, 2391\u20132395 (2013).","journal-title":"Psycho-oncology"},{"key":"32257_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-015-3493-1","volume":"152","author":"E Le Rhun","year":"2015","unstructured":"Le Rhun, E. et al. A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Breast cancer research and treatment 152, 569\u2013580 (2015).","journal-title":"Breast cancer research and treatment"},{"key":"32257_CR5","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1200\/JCO.2011.39.5640","volume":"30","author":"HS Jim","year":"2012","unstructured":"Jim, H. S. et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 30, 3578\u20133587 (2012).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"32257_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10549-014-3044-1","volume":"146","author":"Y Zheng","year":"2014","unstructured":"Zheng, Y. et al. Long-term cognitive function change among breast cancer survivors. Breast cancer research and treatment 146, 599\u2013609 (2014).","journal-title":"Breast cancer research and treatment"},{"key":"32257_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejon.2016.12.007","volume":"27","author":"PJ Oh","year":"2017","unstructured":"Oh, P. J. Predictors of cognitive decline in people with cancer undergoing chemotherapy. Eur J Oncol Nurs 27, 53\u201359 (2017).","journal-title":"Eur J Oncol Nurs"},{"key":"32257_CR8","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/pon.3163","volume":"22","author":"B Collins","year":"2013","unstructured":"Collins, B., MacKenzie, J., Tasca, G. A., Scherling, C. & Smith, A. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psycho-oncology 22, 1517\u20131527 (2013).","journal-title":"Psycho-oncology"},{"key":"32257_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cortex.2014.01.010","volume":"54","author":"J Kaiser","year":"2014","unstructured":"Kaiser, J., Bledowski, C. & Dietrich, J. Neural correlates of chemotherapy-related cognitive impairment. Cortex; a journal devoted to the study of the nervous system and behavior 54, 33\u201350 (2014).","journal-title":"Cortex; a journal devoted to the study of the nervous system and behavior"},{"key":"32257_CR10","first-page":"6","volume":"21","author":"P Andryszak","year":"2017","unstructured":"Andryszak, P., Wilkosc, M., Izdebski, P. & Zurawski, B. A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy. Contemp Oncol (Pozn) 21, 6\u201315 (2017).","journal-title":"Contemp Oncol (Pozn)"},{"key":"32257_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep45135","volume":"7","author":"H Cheng","year":"2017","unstructured":"Cheng, H. et al. Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors. Scientific reports 7, 45135 (2017).","journal-title":"Scientific reports"},{"key":"32257_CR12","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","volume":"30","author":"BC McDonald","year":"2013","unstructured":"McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D. & Saykin, A. J. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain Behav Immun 30, S117\u2013S125 (2013).","journal-title":"Brain Behav Immun"},{"key":"32257_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/cncr.22745","volume":"110","author":"MH Eichbaum","year":"2007","unstructured":"Eichbaum, M. H., Schneeweiss, A. & Sohn, C. Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 110, 224\u2013225 (2007).","journal-title":"Cancer"},{"key":"32257_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/JCO.2011.36.8571","volume":"30","author":"S Deprez","year":"2011","unstructured":"Deprez, S. et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology 30, 274\u2013281 (2011).","journal-title":"Journal of Clinical Oncology"},{"key":"32257_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/hbm.21033","volume":"32","author":"S Deprez","year":"2011","unstructured":"Deprez, S. et al. Chemotherapy\u2010induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human brain mapping 32, 480\u2013493 (2011).","journal-title":"Human brain mapping"},{"key":"32257_CR16","doi-asserted-by":"crossref","unstructured":"McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D. & Saykin, A. J. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast cancer research and treatment 123 (2010).","DOI":"10.1007\/s10549-010-1088-4"},{"key":"32257_CR17","first-page":"123","volume":"65","author":"JS Wefel","year":"2015","unstructured":"Wefel, J. S., Kesler, S. R., Noll, K. R. & Schagen, S. B. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer\u2010related cognitive impairment in adults. CA: a cancer journal for clinicians 65, 123\u2013138 (2015).","journal-title":"CA: a cancer journal for clinicians"},{"key":"32257_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/jnci\/90.3.210","volume":"90","author":"FS van Dam","year":"1998","unstructured":"van Dam, F. S. et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90, 210\u2013218 (1998).","journal-title":"J Natl Cancer Inst"},{"key":"32257_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.neubiorev.2013.04.015","volume":"37","author":"M Simo","year":"2013","unstructured":"Simo, M., Rifa-Ros, X., Rodriguez-Fornells, A. & Bruna, J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neuroscience and biobehavioral reviews 37, 1311\u20131321 (2013).","journal-title":"Neuroscience and biobehavioral reviews"},{"key":"32257_CR20","unstructured":"Golden, C. J., Espe-Pfeifer, P. & Wachsler-Felder, J. Neuropsychological interpretation of objective psychological tests. (Springer Science & Business Media, 2000)"},{"key":"32257_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/arclin\/15.1.31","volume":"15","author":"A Ardila","year":"2000","unstructured":"Ardila, A., Pineda, D. & Rosselli, M. Correlation between intelligence test scores and executive function measures. Archives of clinical neuropsychology 15, 31\u201336 (2000).","journal-title":"Archives of clinical neuropsychology"},{"key":"32257_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jnnp.64.4.492","volume":"64","author":"R Schl\u00f6sser","year":"1998","unstructured":"Schl\u00f6sser, R. et al. Functional magnetic resonance imaging of human brain activity in a verbal fluency task. Journal of Neurology, Neurosurgery & Psychiatry 64, 492\u2013498 (1998).","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"32257_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11065-007-9040-z","volume":"17","author":"MB Jurado","year":"2007","unstructured":"Jurado, M. B. & Rosselli, M. The elusive nature of executive functions: a review of our current understanding. Neuropsychology review 17, 213\u2013233 (2007).","journal-title":"Neuropsychology review"},{"key":"32257_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7334\/psicothema2015.174","volume":"28","author":"A Ardila","year":"2016","unstructured":"Ardila, A., Bernal, B. & Rosselli, M. Connectivity of BA46 involvement in the executive control of language. Psicothema 28, 26\u201331 (2016).","journal-title":"Psicothema"},{"key":"32257_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-15-19","volume":"15","author":"S Wagner","year":"2014","unstructured":"Wagner, S., Sebastian, A., Lieb, K., Tuscher, O. & Tadic, A. A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects. BMC Neurosci 15, 19 (2014).","journal-title":"BMC Neurosci"},{"key":"32257_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.brs.2014.05.007","volume":"7","author":"H Knotkova","year":"2014","unstructured":"Knotkova, H., Malamud, S. C. & Cruciani, R. A. Transcranial direct current stimulation (TDCS) improved cognitive outcomes in a cancer survivor with chemotherapy-induced cognitive difficulties. Brain Stimul 7, 767\u2013768 (2014).","journal-title":"Brain Stimul"},{"key":"32257_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.nicl.2015.02.005","volume":"7","author":"S Menning","year":"2015","unstructured":"Menning, S. et al. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment\u2013the role of fatigue. NeuroImage. Clinical 7, 547\u2013554 (2015).","journal-title":"NeuroImage. Clinical"},{"key":"32257_CR28","doi-asserted-by":"crossref","unstructured":"Kesler, S. R. & Blayney, D. W. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA oncology, 1\u20138 (2015).","DOI":"10.1001\/jamaoncol.2015.4333"},{"key":"32257_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12282-012-0405-7","volume":"21","author":"N Ando-Tanabe","year":"2014","unstructured":"Ando-Tanabe, N. et al. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls. Breast Cancer 21, 453\u2013462 (2014).","journal-title":"Breast Cancer"},{"key":"32257_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuroimage.2008.08.045","volume":"44","author":"GR Ridgway","year":"2009","unstructured":"Ridgway, G. R. et al. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 44, 99\u2013111 (2009).","journal-title":"Neuroimage"},{"key":"32257_CR31","unstructured":"Hayes, A. F. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. (The Guilford Press., 2013)."},{"key":"32257_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/03637750903310360","volume":"76","author":"AF Hayes","year":"2009","unstructured":"Hayes, A. F. Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Commun Monogr 76, 408\u2013420 (2009).","journal-title":"Commun Monogr"},{"key":"32257_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2017.02.013","volume":"54","author":"L Gong","year":"2017","unstructured":"Gong, L. et al. Convergent and divergent effects of apolipoprotein E \u03b54 and \u03b52 alleles on amygdala functional networks in non-demented older adults. Neurobiol Aging 54, 31\u201339 (2017).","journal-title":"Neurobiol Aging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32257-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32257-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32257-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T01:23:28Z","timestamp":1751851408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32257-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32257"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32257-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13801"}}